[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Drugs Market Research Reports & Industry Analysis

The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.

Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.

A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.

Publications found: 8,499
Sort by:

Eastern Equine Encephalitis (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Eastern Equine Encephalitis (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Eastern Equine Encephalitis –...

December 2021 44 pages

Familial Amyloid Neuropathies (Metabolic Disorder) - Drugs in Development, 2021

US$ 2,000.00

Familial Amyloid Neuropathies (Metabolic Disorder) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Familial Amyloid Neuropathie...

December 2021 96 pages

Female Contraception (Women's and Male Health) - Drugs in Development, 2021

US$ 2,000.00

Female Contraception (Women's and Male Health) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Female Contraception – Drugs In...

December 2021 128 pages

Female Sexual Dysfunction (Women's and Male Health) - Drugs in Development, 2021

US$ 2,000.00

Female Sexual Dysfunction (Women's and Male Health) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Female Sexual Dysfunction –...

December 2021 90 pages

Fibrodysplasia Ossificans Progressiva (Myositis Ossificans Progressiva) (Musculoskeletal) - Drugs in Development, 2021

US$ 2,000.00

Fibrodysplasia Ossificans Progressiva (Myositis Ossificans Progressiva) (Musculoskeletal) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipe...

December 2021 88 pages

Glioblastoma Multiforme (GBM) (Oncology) - Drugs in Development, 2021

US$ 2,500.00

Glioblastoma Multiforme (GBM) (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Glioblastoma Multiforme (GBM) – Drugs...

December 2021 3486 pages

Graves' Ophthalmopathy (Ophthalmology) - Drugs in Development, 2021

US$ 2,000.00

Graves' Ophthalmopathy (Ophthalmology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Graves' Ophthalmopathy – Drugs In Develo...

December 2021 117 pages

Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcar...

December 2021 45 pages

Hyperglycemia (Metabolic Disorder) - Drugs in Development, 2021

US$ 2,000.00

Hyperglycemia (Metabolic Disorder) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hyperglycemia – Drugs In Development, 2021,...

December 2021 34 pages

Hyperinsulinemia (Metabolic Disorder) - Drugs in Development, 2021

US$ 2,000.00

Hyperinsulinemia (Metabolic Disorder) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hyperinsulinemia – Drugs In Development,...

December 2021 85 pages

Hyperphosphatemia In Chronic Kidney Disease (Nutritional Disorders) - Drugs in Development, 2021

US$ 2,000.00

Hyperphosphatemia In Chronic Kidney Disease (Nutritional Disorders) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hyperphosph...

December 2021 75 pages

Influenza A Virus, H7N9 Subtype Infections (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Influenza A Virus, H7N9 Subtype Infections (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Influenza A Vir...

December 2021 114 pages

Integrin Beta 7 (Gut Homing Receptor Beta Subunit or ITGB7) - Drugs In Development, 2021

US$ 3,500.00

Integrin Beta 7 (Gut Homing Receptor Beta Subunit or ITGB7) - Drugs In Development, 2021 SUMMARY Integrin Beta 7 (Gut Homing Receptor Beta Subunit or ITGB7) pipeline Target constitutes close to 12 mol...

December 2021 77 pages

Interleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma Antigen NY REN 64 or IRAK4 or EC 2.7.11.1) - Drugs In Development, 2021

US$ 3,500.00

Interleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma Antigen NY REN 64 or IRAK4 or EC 2.7.11.1) - Drugs In Development, 2021 SUMMARY Interleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma...

December 2021 90 pages

Interleukin 7 Receptor Subunit Alpha (CDw127 or CD127 or IL7R) - Drugs In Development, 2021

US$ 3,500.00

Interleukin 7 Receptor Subunit Alpha (CDw127 or CD127 or IL7R) - Drugs In Development, 2021 SUMMARY Interleukin 7 Receptor Subunit Alpha (CDw127 or CD127 or IL7R) – Interleukin-7 receptor is a protein...

December 2021 65 pages

Kidney Cancer (Renal Cell Cancer) (Oncology) - Drugs in Development, 2021

US$ 2,500.00

Kidney Cancer (Renal Cell Cancer) (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Kidney Cancer (Renal Cell Cancer)...

December 2021 4110 pages

Leptin Receptor (HuB219 or OB Receptor or CD295 or LEPR) - Drugs In Development, 2021

US$ 3,500.00

Leptin Receptor (HuB219 or OB Receptor or CD295 or LEPR) - Drugs In Development, 2021 SUMMARY According to the recently published report 'Leptin Receptor – Drugs In Development, 2021'; Leptin Receptor...

December 2021 58 pages

Medulloblastoma (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Medulloblastoma (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Medulloblastoma – Drugs In Development, 2021, provid...

December 2021 556 pages

Meningitis (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Meningitis (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Meningitis – Drugs In Development, 2021, provid...

December 2021 89 pages

Merkel Cell Carcinoma (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Merkel Cell Carcinoma (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Merkel Cell Carcinoma – Drugs In Development,...

December 2021 1010 pages

Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) - Drugs In Development, 2021

US$ 3,500.00

Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) - Drugs In Development, 2021 SUMMARY Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) pipeline Target constitutes close to 7 mo...

December 2021 44 pages

Middle East Respiratory Syndrome (MERS) (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Middle East Respiratory Syndrome (MERS) (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Middle East Respir...

December 2021 179 pages

Multiple Myeloma (Kahler Disease) (Oncology) - Drugs in Development, 2021

US$ 2,500.00

Multiple Myeloma (Kahler Disease) (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Multiple Myeloma (Kahler Disease)...

December 2021 2980 pages

Neuroendocrine Tumors (Oncology) - Drugs in Development, 2021

US$ 2,500.00

Neuroendocrine Tumors (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Neuroendocrine Tumors – Drugs In Development,...

December 2021 1317 pages

Ovarian Cancer (Oncology) - Drugs in Development, 2021

US$ 2,500.00

Ovarian Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ovarian Cancer – Drugs In Development, 2021, provides...

December 2021 5066 pages

Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Peripheral Nerve S...

December 2021 567 pages

Pituitary ACTH Hypersecretion (Cushing Disease) (Metabolic Disorder) - Drugs in Development, 2021

US$ 2,000.00

Pituitary ACTH Hypersecretion (Cushing Disease) (Metabolic Disorder) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pituitary...

December 2021 43 pages

Poliomyelitis (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Poliomyelitis (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Poliomyelitis – Drugs In Development, 2021,...

December 2021 104 pages

Presbyopia (Ophthalmology) - Drugs in Development, 2021

US$ 2,000.00

Presbyopia (Ophthalmology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Presbyopia – Drugs In Development, 2021, provides an...

December 2021 78 pages

Prosthetic joint infections (Musculoskeletal) - Drugs in Development, 2021

US$ 2,000.00

Prosthetic joint infections (Musculoskeletal) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Prosthetic Joint infections – Dru...

December 2021 80 pages

Recurrent Malignant Glioma (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Recurrent Malignant Glioma (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Recurrent Malignant Glioma – Drugs In Dev...

December 2021 56 pages

Retinitis Pigmentosa (Retinitis) (Ophthalmology) - Drugs in Development, 2021

US$ 2,500.00

Retinitis Pigmentosa (Retinitis) (Ophthalmology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Retinitis Pigmentosa (Retiniti...

December 2021 318 pages

Serine/Threonine Protein Kinase A Raf (Proto Oncogene A Raf or Proto Oncogene Pks or ARAF or EC 2.7.11.1) - Drugs In Development, 2021

US$ 3,500.00

Serine/Threonine Protein Kinase A Raf (Proto Oncogene A Raf or Proto Oncogene Pks or ARAF or EC 2.7.11.1) - Drugs In Development, 2021 SUMMARY According to the recently published report 'SerineThreoni...

December 2021 44 pages

Smoothened Homolog (Protein Gx or SMO) - Drugs In Development, 2021

US$ 3,500.00

Smoothened Homolog (Protein Gx or SMO) - Drugs In Development, 2021 SUMMARY Smoothened Homolog (Protein Gx or SMO) – Smoothened homolog (SMO) is a G protein-coupled receptor that probably associates w...

December 2021 91 pages

Survival Motor Neuron Protein (Component Of Gems 1 or Gemin 1 or SMN1 or SMN2) - Drugs In Development, 2021

US$ 3,500.00

Survival Motor Neuron Protein (Component Of Gems 1 or Gemin 1 or SMN1 or SMN2) - Drugs In Development, 2021 SUMMARY Survival Motor Neuron Protein (Component of Gems 1 or Gemin 1 or SMN1 or SMN2) pipel...

December 2021 93 pages

Tinea Pedis (Athlete Foot) (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Tinea Pedis (Athlete Foot) (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Tinea Pedis (Athlete Foot) – Dr...

December 2021 37 pages

Toll Like Receptor 4 (hToll or CD284 or TLR4) - Drugs In Development, 2021

US$ 3,500.00

Toll Like Receptor 4 (hToll or CD284 or TLR4) - Drugs In Development, 2021 SUMMARY Toll Like Receptor 4 (hToll or CD284 or TLR4) – Toll-like receptor 4 is a protein encoded by the TLR4 gene. This rece...

December 2021 144 pages

Toxoplasmosis (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Toxoplasmosis (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Toxoplasmosis – Drugs In Development, 2021,...

December 2021 48 pages

Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline gui...

December 2021 62 pages

Western Equine Encephalitis (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Western Equine Encephalitis (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Western Equine Encephalitis –...

December 2021 33 pages

Zika Virus Infections (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Zika Virus Infections (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Zika Virus Infections – Drugs In Dev...

December 2021 258 pages

Global Vitamin C Market 2021 - Industry Statistics

US$ 750.00

Vitamin C, also known as L-ascorbic acid, is a water-soluble vitamin that is naturally present in some foods, added to others, and available as a dietary supplement. Humans, unlike most animals, are u...

December 2021 70 pages

Global Vitamins Market 2021 - Industry Statistics

US$ 2,800.00

Vitamins are organic substances present in minute amounts in natural foodstuffs. It is an essential micronutrient which an organism needs in small quantities for the proper functioning of its metaboli...

December 2021 88 pages

Global Vitamin B1 Market 2021 - Industry Statistics

US$ 750.00

Vitamin B1, or thiamin (thiamine), is a water-soluble vitamin found naturally in some foods, added to foods, and sold as a supplement. Vitamin B1 plays a vital role in the growth and function of vario...

December 2021 63 pages

Global Vitamin B12 Market 2021 - Industry Statistics

US$ 750.00

Vitamin B12 is an important B vitamin. It is crucial for nerve tissue health, brain function, and the production of red blood cells. The global vitamin B12 market is projected to expand at a CAGR of ~...

December 2021 62 pages

Global Vitamin B6 Market 2021 - Industry Statistics

US$ 750.00

Vitamin B6, or pyridoxine, is a water-soluble vitamin found naturally in many foods, as well as added to foods and supplements. According to latest analysis by Gen Consulting Company, the global vitam...

December 2021 61 pages

Global Vitamin B7 Market 2021 - Industry Statistics

US$ 750.00

Vitamin B7, also known as biotin, vitamin H, is a water-soluble vitamin that helps the body metabolize fats, carbohydrates, and protein. Vitamin B7 supplements are often glamorized as a treatment for...

December 2021 73 pages

Global Vitamin B9 Market 2021 - Industry Statistics

US$ 750.00

Vitamin B9, also called folate or folic acid, is one of 8 B vitamins. All B vitamins help the body convert food (carbohydrates) into fuel (glucose), which is used to produce energy. According to marke...

December 2021 60 pages

Global Vitamin B2 Market 2021 - Industry Statistics

US$ 750.00

Vitamin B2, or riboflavin, is one of eight B vitamins that are essential for human health. It is essential to the formation of two major coenzymes, flavin mononucleotide and flavin adenine dinucleotid...

December 2021 72 pages

Global Vitamin D3 Market 2021 - Industry Statistics

US$ 750.00

Vitamin D helps regulate the amount of calcium and phosphate in the body. These nutrients are needed to keep bones, teeth and muscles healthy. In humans, the most important compounds in this group are...

December 2021 65 pages

Filters

Search

Publishers

1
2
1
95
4
1
27
16
4
14
1
3
174
29
9
2,264
5
4
22
51
6
142
16
1
17
1
15
23
651
79
1
373
16
586
4
1
1
2
16
1,197
6
166
4
84
31
2
36
3
5
4
118
187
13
16
4
2
7
15
110
2
10
50
16
26
4
2
17
4
2
1
11
32
8
15
4
24
118
49
2
1
19
4
7
3
324
11
1
1
23
31
4
11
3
1
499
24
2
5
29
44
294
17
17
13
5
18
2

Regions

614
11
4
9
6
12
6
273
158
54
47
41
41
39
37
17
16
16
16
15
14
14
14
14
14
13
13
13
13
13
13
13
13
13
12
12
11
11
11
10
10
10
10
10
10
9
9
9
9
9
9
9
9
8
7
7
6
6
6
5
4
4
4
3
192
10
5
4
4
4
4
4
3
3
3
3
3
3
1
1
7
6
3
8
2
1
2
183
1
5
3
11
11
7
5
16
9
6
16
14
4
150
248
5,652
11

Price

Date

Pages

Offers

13
7
9
1
498